Pharmacy Times March 3, 2025
Gillian McGovern, Associate Editor

Key Takeaways

  • The Pixel Watch 3’s Loss of Pulse Detection feature automatically contacts emergency services if no pulse is detected and the wearer is unresponsive.
  • Optical heart rate sensors and AI are used to detect pulse absence, prompting alerts and potential emergency calls.
  • Developed with cardiologists, the feature was tested across diverse groups and scenarios to ensure efficacy.
  • While enhancing safety, the feature is not a diagnostic tool and should not replace professional medical advice.
  • Currently available in 14 countries, with plans for expansion as regulatory clearances are obtained.

The feature is expected to be available to US users in late March 2025.

The FDA granted clearance to Google’s Pixel Watch 3 for its Loss of Pulse Detection...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Technology, Wearables
Smartwatch Motivates Patients With Diabetes to Stay Active
Scientists unveil starfish-inspired wearable tech for heart monitoring
CVS Caremark taps Omada on GLP-1 program
Improving Diabetes Care Through Access to Continuous Glucose Monitors in Medicaid: State Opportunities
Shoes that can warn you of injuries? How wearable technology is transforming foot care

Share This Article